Cargando…
Novel targets for ATM-deficient malignancies
Conventional chemo- and radiotherapies for the treatment of cancer target rapidly dividing cells in both tumor and non-tumor tissues and can exhibit severe cytotoxicity in normal tissue and impair the patient's immune system. Novel targeted strategies aim for higher efficacy and tumor specifici...
Autores principales: | Winkler, Johannes, Hofmann, Kay, Chen, Shuhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4905167/ https://www.ncbi.nlm.nih.gov/pubmed/27308314 http://dx.doi.org/10.4161/mco.29905 |
Ejemplares similares
-
ATM-Deficient Cancers Provide New Opportunities for Precision Oncology
por: Jette, Nicholas R., et al.
Publicado: (2020) -
Targeting ATM-deficient CLL through interference with DNA repair pathways
por: Knittel, Gero, et al.
Publicado: (2015) -
ATM: Functions of ATM Kinase and Its Relevance to Hereditary Tumors
por: Ueno, Sayaka, et al.
Publicado: (2022) -
1000 atm. hydrogen target
por: CERN PhotoLab
Publicado: (1971) -
Deficiency of the DNA repair enzyme ATM in rheumatoid arthritis
por: Shao, Lan, et al.
Publicado: (2009)